IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4
Mingli Ni(Luoyang Central Hospital Affiliated to Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Ling Xie(University of North Carolina at Chapel Hill), Mingyue Yang(Luoyang Central Hospital Affiliated to Zhengzhou University), Beibei Qin(Zhejiang University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Jiezhi Yang(Luoyang Central Hospital Affiliated to Zhengzhou University), Hongqiong Lv(Luoyang Central Hospital Affiliated to Zhengzhou University)
Cited by 9
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134